Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine occur without parallel glial cell reactions-Reference-Cited by-同舟云学术

Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine occur without parallel glial cell reactions

Published:1993-10 Issue:1-2 Volume:624 Page:35-43
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Rowland N.E.,Kalehua A.N.,Li B.-H.,Semple-Rowland S.L.,Streit W.J.

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference30 articles.

1. Major histocompatibility complex antigen expression on rat microglia following epidural kainic acid lesions;Akiyama;J. Neurosci. Res.,1988

2. The kinetics and morphological characteristics of the macrophage-glial response to kainic acid-induced neuronal degeneration;Andersson;Neuroscience,1991

3. Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies;Appel;J. Pharmacol. Exp. Ther.,1989

4. The serotonin-producing neurons of the midbrain median and dorsal raphe nuclei;Azmitia,1978

5. Perineuronal glial responses after axotomy of central and peripheral axons. A comparison;Barron;Brain Res.,1990

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of MDMA on the Human Nervous System;The Effects of Drug Abuse on the Human Nervous System;2014

2. Glial Cell Response to 3,4-(±)-Methylenedioxymethamphetamine and Its Metabolites;Toxicological Sciences;2013-12-03

3. Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation;Pharmaceuticals;2011-07-05

4. Ultrastructural characterization of tryptophan hydroxylase 2-specific cortical serotonergic fibers and dorsal raphe neuronal cell bodies after MDMA treatment in rat;Psychopharmacology;2010-10-30

5. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation;Clinical Toxicology;2010-08